Filing
2nd Quarter - Report
Bills named in this filing
1
Lobbying activity
3
Drug pricing proposals. Pharmacy Benefit Manager reform proposals. 340B. Vaccine access issues.
Tax policy impacting health care and pharmaceutical industry. OBBB.
Drug pricing proposals. Pharmacy Benefit Manager reform proposals. H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN. Implementation of IRA.